Simply Wall Street Earnings
Medtronic (MDT) Faces Fresh Scrutiny On $88 Million Verdict As Fair Value Stays In Focus
Medtronic (MDT) is under scrutiny after a federal jury ordered it to pay US$88 million for hernia mesh products, a verdict the company plans to challenge. Despite this, Medtronic's stock has seen recent improvements, though its one-year return remains muted. The article discusses Medtronic's fair value, which is closely aligned with its current share price, and also presents …